Primary Antibody

JAK3 (6B5) Mouse mAb

  • Catalog Number : AM33098
  • Number : AM33098
  • Size:
    Qty :
  • Price : Request Inquiry
  • Download DataSheet print

General Information

Reactivity Human, Mouse, Rat
Application IHC
Host Mouse
Clonality Monoclonal
Conjugate Non-conjugated
Immunogen Synthesized peptide derived from human JAK3
Molecular Weight 125kD (Observed)
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instruction -15°C to -25°C/1 year(Do not lower than -25°C)
Research topic >>Chemokine signaling pathway>>PI3K-Akt signaling pathway>>Necroptosis
Alias Tyrosine-protein kinase JAK3
Janus kinase 3
JAK-3
Leukocyte janus kinase
L-JAK
Recommended Dilution Ratio

IHC 1:50-200

Specificity

This antibody detects endogenous levels of JAK3 at Human, Mouse,Rat

Purification

The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.

Gene Name

JAK3

Protein Name

JAK3

Database Link
Organism Gene ID SwissProt
Human 3718 P52333
Mouse 16453 Q62137
Rat   Q63272
Background

The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008].

Function

Catalytic activity:ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.,Disease:Defects in JAK3 are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-)SCID) [MIM:600802]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.,Domain:Possesses two phosphotransferase domains. The second one probably contains the catalytic domain (By similarity), while the presence of slight differences suggest a different role for domain 1.,Function:Tyrosine kinase of the non-receptor type, involved in the interleukin-2 and interleukin-4 signaling pathway. Phosphorylates STAT6, IRS1, IRS2 and PI3K.,online information:JAK3 mutation db,PTM:Tyrosine phosphorylated in response to IL-2 and IL-4.,similarity:Belongs to the protein kinase superfamily. Tyr protein kinase family. JAK subfamily.,similarity:Contains 1 FERM domain.,similarity:Contains 1 protein kinase domain.,similarity:Contains 1 SH2 domain.,subcellular location:Wholly intracellular, possibly membrane associated.,subunit:Interacts with STAM2 and MYO18A (By similarity). Interacts with SHB.,tissue specificity:In NK cells and an NK-like cell line but not in resting T-cells or in other tissues. The S-form is more commonly seen in hematopoietic lines, whereas the B- and M-forms are detected in cells both of hematopoietic and epithelial origins.

Cellular Localization

Endomembrane system ; Peripheral membrane protein . Cytoplasm .

Tissue Expression

In NK cells and an NK-like cell line but not in resting T-cells or in other tissues. The S-form is more commonly seen in hematopoietic lines, whereas the B-form is detected in cells both of hematopoietic and epithelial origins.

Validation Data

 

Immunohistochemical analysis of paraffin-embedded Human Lung CarcinomaTissue using JAK3 Mouse Monoclonal antibody diluted at 1:200.

Recently Viewed Products

gotop link
Customized Product Contact Us
0